According to a recent study, Gen X and Y are demonstrating higher levels of unhealthy behaviors and poorer physical health, in comparison with older generations. The study was reported in the “American Journal of Epidemiology” on March 18, 2021.
Since the 21st century begun, mortality and morbidity has been growing among younger and middle-aged Americans. Researchers from the Ohio State University, Columbus looked into these unfavorable trends to discover whether they extended to the younger generations and their basal behavioral, psychological and physiological mechanisms.
The researchers — Paola Echave and Hui Zheng — studied trends in physical and mental health among two groups of grown-up who took part in the NHIS and the NHANES surveys, between 1997–2018 and 1988–2016 respectively.
They discovered that for every racial and gender group, physiological dysregulation had grown continuously from individuals born between 1946 and 1964, commonly referred to as baby boomers, through people born between 1965 and 1979/80, known as Generation X, and individuals born between 1981 and 1994/1996, commonly referred to as Generation Y. Baby boomers are currently aged between 57 and 75 years old, Gen X individuals are currently aged between 41 and 56 years old, while Gen Y individuals are now aged between 25 and 40 years old.
The researchers found that Black males had the highest increase in low urinary albumin, which is a marker for chronic inflammation, while the magnitude of increase was higher for white males, in comparison with other groups.
Additionally, their findings show that levels of depression and anxiety had increased for every generation of white individuals, from those born in the years 1943 to 1945 (the war babies generation) through Generation Y.
The researchers also observed an increase in heavy drinking across all generations for Black and white men, especially after Generation X. This is in addition to higher levels of smoking and drug use in comparison with their Hispanic and Black counterparts.
The researchers discovered that the probability of using drugs grew with late boomers before declining and then increasing again for Generation X.
In addition to this, they found that smoking was not the cause of the growing physiological dysregulation among the different groups. Finally, obesity was found to be a contributing factor to the rise in metabolic syndrome but not the increase of chronic inflammation that was observed.
In their report, the authors noted that the worsening mental health and physiological profiles among younger generations signaled a rather difficult mortality and morbidity prospect for Americans, one that could be especially unfavorable for white individuals.
Many biomedical firms, such as Predictive Oncology (NASDAQ: POAI), are doing what they can to find customized solutions to the myriad health challenges people face.
NOTE TO INVESTORS: The latest news and updates relating to Predictive Oncology (NASDAQ: POAI) are available in the company’s newsroom at http://ibn.fm/POAI
About BioMedWire
BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information, please visit https://www.BioMedWire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
[email protected]
BioMedWire is part of the InvestorBrandNetwork.